#USA #New York #Pomerantz #MoonLake #MLTX

Investor Alert: Pomerantz Law Firm Investigates MoonLake Immunotherapeutics

Overview

Pomerantz LLP, a well-established law firm known for its advocacy on behalf of investors, is currently conducting an investigation into claims associated with MoonLake Immunotherapeutics, a company listed on NASDAQ under the ticker MLTX. This investigation is prompted by allegations that MoonLake, alongside certain executives and directors, has potentially engaged in securities fraud and other unlawful business practices.

Recent Developments

On September 28, 2025, MoonLake disclosed unsatisfactory results from its Phase 3 VELA trials aimed at assessing the effectiveness and safety of sonelokimab, a drug in development. The announcement revealed that one of the trials did not achieve its primary goal, while the other only indicated marginal improvements compared to a placebo. Following this alarming news, the company's stock price dramatically plummeted by $55.75 per share, representing a staggering decrease of nearly 90%, closing at $6.24 on the following day.

This sharp decline in stock value has raised significant concerns among investors, prompting the call for engagement with Pomerantz LLP. Investors affected by these negative developments are encouraged to reach out to Danielle Peyton at Pomerantz for further guidance and support regarding potential claims.

The Role of Pomerantz LLP

Pomerantz LLP, with its international presence spanning cities like New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, has established itself as a premier firm specializing in corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, a pioneer in the field of securities class actions, the firm has a history of fighting for the rights of victims of securities fraud and corporate misconduct. With over 85 years of experience, Pomerantz has successfully secured numerous multimillion-dollar settlements for its clients, reinforcing its reputation in the legal community.

Legal Resources for Investors

As the investigation unfolds, investors are advised to stay informed and reach out to legal experts for support. Pomerantz LLP is actively looking to connect with those who might have experienced losses due to the alleged misconduct of MoonLake and its management. Potential participants can find more information on joining a class-action lawsuit and discuss their situations with knowledgeable attorneys, who can provide insights into their legal options.

More details regarding the investigation and contact information for the firm can be accessed through the appropriate channels provided by Pomerantz LLP. Investors must stay vigilant during this period and seek legal counsel to navigate the complexities associated with securities fraud allegations.

Conclusion

The case against MoonLake Immunotherapeutics serves as a critical reminder of the inherent risks associated with investing in biotech firms, particularly those undergoing rigorous clinical trials. With the involvement of a reputable firm like Pomerantz LLP, investors have an opportunity to seek justice and potentially recover their losses. It is crucial for affected investors to act swiftly and connect with legal resources to ensure their rights are protected amidst the ongoing investigation.